Elevance Looks Cheap Now: But is it Time to Buy or Dodge?

Elevance Health, Inc. (ELV) , a leading U.S. health benefits provider, appears to be trading at a discount. Its forward 12-month P/E ratio stands at just 10.35X, significantly below its five-year median of 13.46X and the industry average of 13.86X. Compared to peers, UnitedHealth Group Incorporated (UNH) and Humana Inc. (HUM) , which trade at 12.06X and 14.73X, respectively, ELV looks attractively valued. It currently holds a Zacks Value Score of A, highlighting strong valuation fundamentals.But is this dis ...